Since 2012, China heart drug sold globally may have had impurity linked to cancer
The revelation that the problem likely dates back to changes in manufacturing processes at Zhejiang Huahai Pharmaceutical six years ago suggests many patients could potentially have been exposed to cancer risk.
Jul 18, 2018, 11:53 AM IST